Staphylococcus aureus colonizes the skin of atopic dermatitis (AD) individuals, but the impact of its enterotoxins on the chronic activation of CD4
www.nature.com/scientificreports www.nature.com/scientificreports/ filaggrin and human β-defensin 3) and release of Th2-associated cytokines, favor S. aureus skin penetration in AD subjects [16] [17] [18] [19] . Staphylococcal exotoxins can promote the release of proinflammatory mediators from cutaneous cells and lead to subsequent pruritus and scratching, binding to specific IgE on the surface of Langerhans cells, facilitating allergen presentation, and activation of specific T cells 20 . Cutaneous S. aureus is also accomplished of inducing differentiation of Gr1 + CD11b + myeloid-derived suppressor cells, leading to immune suppression of T cell activation in skin, and decreased numbers of splenic CD4 + and CD8 + T cells in mouse models 21 . Effector memory T cells driven against antigens derived from cutaneous pathogens, such as S. aureus, are essential for providing rapid defense against infections 22 . The hallmark functions of CD4 + T cells include cytokine production and optimization and maintenance of CD8 T cell memory 23 . Polyfunctional T cells comprise distinct functional subsets of effector T cells with the ability to produce and release different combinations of cytokines during the course of the immune response 24 . Compared with subsets that secrete single cytokines, polyfunctional T cells provide more effective, long-lasting protection and enhance other effector functions 9, [25] [26] [27] , making them an interesting target for vaccine and immunotherapies designs that are dependent on cellular responses [28] [29] [30] [31] . However, whether polyfunctional T cells could be involved in AD have never been assessed.
In this paper, we present a novel approach to study the status of CD4 + T cells in AD based on their polyfunctional profile. By analyzing the phenotypic features of CD4 + T cells exposed to staphylococcal enterotoxins, we observed impairment in the ability of chronically activated cells from AD patients to develop a polyfunctional response. These superantigens seem to reshape the genetic program of those cells into an anergic profile that may contribute to the chronicity of AD.
Results
Staphylococcal enterotoxin triggers a broad tolerogenic genetic program. Considering the chronic nature of S. aureus colonization and the known defects in effector immune response in AD patients, we propose that staphylococcal enterotoxins can drive CD4 + T cell from AD patients to a tolerogenic profile. In order to test this hypothesis, we performed a PCR array for 84 key genes related to T-cell anergy and immune tolerance in cell-sorted CD4 + T cells from PBMC upon SEA stimulation. As illustrated in the heatmap (Fig. 1a) and the volcano plots ( Supplementary Fig. S1 ), a multitude of anergy related genes are upregulated in AD patients, including the classical AD associated ones IL4 and IL13; the last one has been also validated by conventional qPCR (Fig. 1c) . It should be highlighted that most of the screened genes + T cells analyzed by PCR array. The genes were classified according to functional criteria expressed on a thermal scale for HC (n = 3) and AD patients (n = 3) at baseline and after SEA stimulation. Expression of upregulated genes EGR2 (b) and IL13 (c) was confirmed by RT-qPCR (n = 8-9). Bars represent median with interquartile range. *p < 0.05.
www.nature.com/scientificreports www.nature.com/scientificreports/ have never been linked to AD, which may open new venues for investigation. However, a previous genome-wide association study by Hirota et al. 32 suggested that the early growth response (EGR) EGR2, a negative regulator of T cell activation 33 , could be a susceptibility locus for AD. Notably, we found significant expression of EGR2 in AD patients, which was validated by conventional qPCR (Fig. 1b) . These findings indicate that SEA is able to arrest the CD4 + T cell of AD patients to an anergic program, which may account greatly for their impaired immune response.
Staphylococcal enterotoxins compromises CD4
+ T cell polyfunctional profile in AD. In previous studies, our group demonstrated a diminished peripheral blood mononuclear cells (PBMCs) proliferation response to staphylococcal enterotoxin A (SEA) and other antigens and mitogens (Tetanic toxoid, TT; Candida albicans membrane antigen, CMA; and phytohemagglutinin, PHA), suggestive of a defective immune profile in adults with AD 34 . In line with the anergic response observed above, the CD4 + T cell response seems to be affected in AD.
Considering the relevance of Th1, Th2, Th22 and Th17 axes to AD immunopathogenesis, first, we evaluated the influence of staphylococcal enterotoxins (SEA and SEB) on CD4 + T cells producing IFN-γ, IL-17A, IL-22, MIP-1β and TNF according to the gating strategy shown in Fig. 2a . Curiously, when we considered the phenotype based on single staining for each cytokine (Fig. 2b) , AD-derived CD4 + T cells were as efficient as health controls in IFN-γ and TNF production, apparently arguing against our depressed immune response hypothesis.
However, instead of a single cytokine response, a polyfunctional phenotype should be more representative of a cell activity and it has been associated with beneficial immune responses 28 . Therefore, we next aimed to analyze the CD4 + T cells ability to simultaneously produce the above cytokines upon SEA stimulation. Due to the great amount of data generated in polyfunctional analysis ( Supplementary Fig. S2 ), a PCA was applied to understand the groups' dynamics in response to SEA.
As shown in Fig. 2c , we observed that HC display a remarkable polyfunctional response, moving from a condensed basal cluster toward a dispersed distribution pattern after SEA addition. Strikingly, AD patients showed a compromised profile upon the same stimulation, seen by the similar dispersion and partial overlay of both www.nature.com/scientificreports www.nature.com/scientificreports/ clusters (basal and SEA stimulated), which suggests that the basal CD4 + cell response is already altered in AD and SEA exerts a mild effect in promoting cytokine production. Thus, this impaired cytokine profile in AD patients to staphylococcal enterotoxins may reflect an unresponsive status of their CD4 + T cells.
CD4
+ T cells in AD patients are chronically activated but show reduced polyfunctional response to SeA stimulation. The persistent skin colonization by S. aureus may drive a chronic activation of the immune system. This activation status can be monitored in a T cell through changes in phenotypic markers, such as CD38, a chronic activation marker already reported in CLA
+ T cells from individuals with extrinsic AD 35 . CD38 expression is also found in thymocytes, B lymphocytes, circulating monocytes, natural killer cells and granulocytes 36 , and reflects a T cell activation in response to microbial infection or vaccination 37 . Thus, in order to filter the above results, we next investigated whether a differential polyfunctional profile could be detected based on the CD38 expression.
Initially, we evaluated the marker expression in CD4 + T cells, according to the gating strategy shown in Fig. 3a , and we detected an increased frequency in AD patients in unstimulated condition (Fig. 3b) , corroborating the chronic activation profile classically seen in those patients.
Curiously, in CD4 + CD38 − T cells, AD lymphocytes responded to SEA similarly to HC counterparts (Figs 3c, S3). However, when focusing on the CD4
+ CD38 + population, we could recapitulate the deficient response of total CD4 + cells in AD (Figs 3d, S4 ), reproducing the mild changes in cluster dynamics between basal and SEA stimulation in AD group. Therefore, the total CD4 + T cell response is in fact heterogeneous and the prevalent anergy profile seems to be restricted to CD38 + subsets. Thus, our data reinforces the need to understand the CD4 + T cell response at the subpopulation level. Together, our findings indicate that ex vivo CD4 + CD38 + T cells are chronically activated in AD patients and show compromised polyfunctional response to staphylococcal antigens. 11 ; altogether emphasizing their Th2/T22-biased response 11 . In addition, adult patients with AD have defective antigen-specific and polyclonal proliferative responses 34 , suggesting an immunosuppressed profile in their CD4 + T cell compartment. Although healthy individuals can be exposed to staphylococcal superantigens, we hypothesize that AD patients may show an altered response to antigenic stimulation 34, 39 . Previous works addressing the role of staphylococcal exotoxins in AD, including both children and adults, showed an immunostimulatory rather than an immunosuppressive effect 7, 40, 41 , albeit those contradictory responses could be due to the nature of the antigen utilized and the patients' age.
By broadly screening the expression of genes related to T cell anergy, we observed a marked induction of EGR2 expression by SEA stimulation. The EGR genes EGR2 and EGR3 were previously associated with anergy and negative regulation of T cell function 33 , with EGR2 also described as a susceptibility locus for AD at genome-wide significance in the Japanese population, and reported as a candidate gene associated with regulatory T cells 32, 42 . Although its expression was demonstrated in murine regulatory T cells (CD4 + CD25 -LAG3 + ) 43 our present data brings new human experimental evidence that reinforces the possible link between this gene and AD.
Additionally, our current data on T lymphocyte polyfunctionality adds a new layer of complexity to the biology of CD4 + T cells in AD pathogenesis, as we detected a downregulatory effect by staphylococcal enterotoxins on cytokine secretion in AD subjects. Interestingly, this response is remarkably limited to CD4 + CD38 + T cells, indicating that they may contribute to disease chronicity and persistent inflammation.
While the current paradigm in CD4 T cell biology considers chronic infections to be a trigger for anergy and T cell hyporesponsiveness, persistent and low-grade exposure to antigens is, in fact, essential for maintenance of polyfunctional T cells 23, 26 , which may explain the heightened basal response in AD patients. Thus, multiparametric flow cytometry studies reveal a large phenotypic and functional heterogeneity in T cell responses, highlighting the importance of assessing multiple attributes of T cell function to predict the outcome of infections, the course of immune diseases and the success of vaccination protocols 23, 44 . Novel therapeutic options in AD aiming immune system via microbiome modulation, should focus on host-pathogen interaction, associating specific effector T-cell subsets with specific neutralizing anti-toxins antibodies. Future therapeutic targets strategies for AD should consider the interaction between host and pathogen, by focusing on cytokine release by activated effector T cells population-level responses to pathogens such as staphylococcal enterotoxins 19, 45, 46 .
In conclusion, our findings help to corroborate the pathogenic role of staphylococcal enterotoxins in modulating the cytokine release by activated effector T cells. Altered gene expression, such as EGR2 induction, and impaired polyfunctional response may contribute to the negative regulation of these activated CD4 + T cells in adults with AD. Our data reveal fundamental insights into how individual cells dynamically modulate intercellular signals to affect population-level responses to pathological conditions or clinical interventions.
Methods
Subjects. Fifteen AD patients (aged between 20-43 years; mean age: 28.53 ± 7.67; 9 males and 6 females), and 10 healthy non-AD volunteers (aged between 20-41 years; mean age: 29.7 ± 6.43; 7 males and 3 females) were included in this study. AD was diagnosed agreeing with the Hanifin & Rajka criteria 47 . Disease severity was assessed by the EASI (Eczema Area and Severity Index) 48 , and AD patients were categorized as mild (n = 2), moderate (n = 8), or severe (n = 5). IgE serum levels varied from 2,680 to 119,000 IU/mL (average of 25,437). None of the patients were under immunosuppressants or oral steroids treatment. This study was according to the Ethics Committee of the University of Sao Paulo School of Medicine, and informed consent was obtained from all subjects. All methods were achieved in accordance with the pertinent guidelines and regulations of this institution. Demographic information is shown in Table 1 .
CD4
+ t cell sorting. PBMCs (50 × 10 6 /mL) were incubated with anti-CD3-Horizon BV605 (10 μL -Clone: SK7/BD Bioscience), anti-CD4-Horizon V450 (10 μL -Clone: RPA-T4/BD) and anti-CD8-PerCP-Cy 5.5 (20 μL -Clone: RPA-T8/BD) for 30 minutes at 4 °C. The cells were washed in 1x sterile PBS (1 mL) and resuspended in RPMI 1640 medium (1 mL, Gibco) supplemented with 10% of human AB serum (Sigma). Cell sorting was performed with a FACSAria III cell sorter (BD Biosciences), and a 99% pure population of 2.5 × 10 6
CD3
+ CD4 + CD8 − cells (CD4 + T cells) was collected.
t cell anergy pcR array. FACS-sorted CD4
+ T cells (2 × 10 6 /mL) were assessed under unstimulated conditions and after staphylococcal enterotoxin A (SEA) stimulation (0.1 μg/mL) for 3 hours, at 37 °C and 5% CO 2 . Total cellular RNA was extracted from CD4 + T cells using an RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA). The first strand of cDNA was synthesized using the RT 2 First Strand kit and PreAMP kit (Qiagen) according to the manufacturer's instructions, and the final cDNA product was used for the RT 2 Profiler PCR Array using SYBR Green-based real-time PCR according to the manufacturer's protocol (PAHS-074Z Array, Qiagen). The array consisted of a panel of 84 genes relevant to T cell anergy and immune tolerance (Fig. 1a) plus five reference genes (B2M, HPRT1, RPL13A, GAPDH and ACTB), a genomic DNA control, three reverse transcription controls and three PCR quality controls. . Data were presented as the log 2 of the relative expression values in a heatmap generated by the R software (v3.3.2. for Windows) with the following packages: gplots and RColorBrewer. Volcano plots were created using the software "R" for Mac OS X GUI (v3.6.0; package "ggplot2") based on the fold change and p-values between atopic dermatitis patients and health controls.
Rt-qpcR.
The final cDNA product was generated from FACS-sorted CD4 + T cells under unstimulated conditions and after SEA stimulation. Reverse transcription was performed using an iSCRIPT Reverse Transcriptase kit (Bio-Rad, Hercules, California, USA).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed in an Applied Biosystems 7500 system using specific primers and SYBR Green (Applied Biosystems, Carlsbad, CA, USA), as described by Pereira et al. 51 . Primers for RT-qPCR (Life Technologies), were only used if their efficiency achieved 100 ± 10%. Adjustments were made for primer efficiency. The specificity of the reaction was assessed by dissociation curve. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels of the samples in the same plate were analyzed to normalize the mRNA contents among the tested samples. The cycling protocol comprised of 10 minutes at 95 °C, followed by 40 cycles of 15 seconds at 95 °C, and 60 seconds at 60 °C. The amplification results were evaluated using Sequence Detection System (SDS) software (Applied Biosystems). ΔCt was calculated as the difference between the Ct value of a gene and the geometric average of the Ct values of the reference genes. Log-fold differences in expression were reported using the 2−ΔΔCt or 2−ΔCt as described by Livak 49 . The following primers were used: EGR2 gene: forward primer (5′-ACGTCGGTGACCATCTTTCC-3′) and reverse primer (5′-GTTGATCATGCCATCTCCGG-3′); IL13 gene: forward primer (5′-GCAATGGCAGCATGGTA TGG-3′) and reverse primer (5′-CTGCACAGTACATGCCAGCT-3′); and GAPDH gene: forward primer (5′-GAAGGT GAAGGTCGGAGT-3′) and reverse primer (5′-GAAGATGGTGATGGGATTTC-3′).
Flow cytometry. Peripheral blood mononuclear cells (PBMCs) from heparinized venous blood were isolated with a Ficoll-Hypaque (GE Healthcare, Uppsala, Sweden) gradient and resuspended in RPMI 1640 medium supplemented with gentamicin (40 µg/mL) and 10% pooled AB normal human serum (Sigma-Aldrich, St Louis, MO, USA). PBMCs (2 × 10 6 /well) were cultivated in 96-well microplates (Costar) at 37 °C and 5% CO 2 in the presence of SEA (0.04 µg/mL; Sigma) for 6 hours. Brefeldin A (10 µg/mL; Sigma) was added 2 hours after the culture was initiated. Next, the cells were stained with a PE-Texas Red LIVE/DEAD viability marker (Invitrogen, Carlsbad, CA, USA) for 30 minutes at room temperature. Cells were then incubated with Cytofix/Cytoperm (BD Biosciences, San Jose, CA, USA) and stained with the following antibodies: anti-CD3-Qdot 605 (Invitrogen), anti-CD4-Horizon V500 (BD), anti-CD8-PerCP-Cy5.5 (BD), anti-TNF-PE-Cy7 (BD), anti-CD38-Alexa 700 (BD), anti-IL-17A-Alexa 488 (eBioscience, San Diego, CA, USA), anti-IL-22-PE (eBioscience), anti-MIP-1β-APC-H7 (BD) and anti-IFN-γ-Horizon V450 (BD Biosciences). Cells were then fixed with 1% paraformaldehyde, and 400,000 events were acquired on an LSR Fortessa flow cytometer (BD Biosciences). Fluorescence minus one (FMO) controls were performed for all antibody panels to check for proper compensation and to define positive signals. Data analysis was performed using FlowJo v10 software (Tree Star, Ashland, OR, USA). After gates were created to define each individual function, we used the Boolean gate platform of the FlowJo software to create an array of possible cytokine combinations. Principal Component Analysis (PCA) of the polyfunctional profile was made in R software (v3.5.1, for Windows) with the following packages: ggplot2 and ggbiplot. Table 1 . Demographic data of adults with AD. AD = atopic dermatitis; HC = healthy controls; M = male; F = female; EASI = Eczema Area and Severity Index; NA = not applicable.
